Short interest in Gain Therapeutics Inc (NASDAQ:GANX) increased during the last reporting period, rising from 572.01K to 658.34K. This put 2.71% of the company's publicly available shares short.

Short interest for Gain Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Gain Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 416.09K shares traded per day, it would take 1.58 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.